Life Technologies ( LIFE) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 1.4%. By the end of trading, Life Technologies fell 65 cents (-1.4%) to $45.64 on heavy volume. Throughout the day, 2.7 million shares of Life Technologies exchanged hands as compared to its average daily volume of 1.7 million shares. The stock ranged in price between $45.25-$47 after having opened the day at $46.93 as compared to the previous trading day's close of $46.29. Other company's within the Health Care sector that declined today were: Idera Pharmaceuticals ( IDRA), down 20.3%, NeurogesX ( NGSX), down 10.8%, Chemocentryx ( CCXI), down 8.5%, and Anthera Pharmaceuticals ( ANTH), down 7.5%. Life Technologies Corporation operates as a global life sciences company. Life Technologies has a market cap of $8.2 billion and is part of the health services industry. The company has a P/E ratio of 22.4, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 19% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Life Technologies a buy, no analysts rate it a sell, and six rate it a hold. TheStreet Ratings rates Life Technologies as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.
- You can view the full Life Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.